OPKO Health Announces Redemption of Series A Preferred Stock

MIAMI--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE Amex: OPK) today announced the completion of the redemption of its Series A Preferred Stock. Of the 722,700 shares of our Series Preferred Stock outstanding as of March 31, 2011, 602,758 shares were redeemed for cash of $2.50 per share plus $0.35 of accrued, unpaid dividends, and 119,942 shares were converted, prior to redemption, into shares of our Common Stock, on a one-to-one basis.

About OPKO Health, Inc.

We are a multi-national pharmaceutical and diagnostics company that seeks to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development and commercialization expertise and our novel and proprietary technologies. Our current focus is on conditions with major unmet medical needs including neurological disorders, infectious diseases, oncology and ophthalmologic diseases.

    Source: OPKO Health, Inc.